All Types of Visual Impairment Linked to Dementia Prevalence
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 14, 2023 -- All types of visual impairment (VI) and contrast sensitivity (CS) are associated with increased prevalence of dementia in U.S. older adults, according to a study published online July 13 in JAMA Ophthalmology.
Olivia J. Killeen, M.D., from the University of Michigan in Ann Arbor, and colleagues estimated the association between VI and dementia in older U.S. adults based on objective visual and cognitive function testing in a secondary analysis of the 2021 National Health and Aging Trends Study. Data were included for 2,967 participants, with a median age of 76.9 years.
The researchers found that the weighted prevalence of dementia was 12.3 percent; prevalence increased with near VI (21.5 percent), distance VI (mild: 19.1 percent; moderate, severe, or blind: 32.9 percent), and CS impairment (25.9 percent). After adjustment for covariates, the prevalence of dementia was higher for those with near VI and CS impairment compared with those without (prevalence ratios, 1.40 and 1.31 for near VI and CS impairment, respectively) and among those with moderate-to-severe distance VI or blindness (prevalence ratio, 1.72).
"All types of objectively measured VI were associated with a higher dementia prevalence," the authors write. "Thus, prioritizing vision health may be key to optimizing both sight and overall health and well-being."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Lower Cognitive Function in Adolescence Linked to Stroke Risk
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.